An Insight into Primary Congenital Glaucoma

Area of Science:

• Ophthalmology
• Genetics
• Pediatrics

Background:

• Glaucoma is a leading cause of vision impairment globally, with primary congenital glaucoma (PCG) affecting newborns and young children.
• PCG, a significant cause of childhood blindness, has an unknown etiology and varying prevalence across populations.
• This condition results from genetic defects in the eye's trabecular meshwork, leading to elevated intraocular pressure (IOP).

Purpose of the Study:

• To summarize the current understanding of primary congenital glaucoma (PCG) as a cause of childhood blindness.
• To highlight the genetic basis, clinical manifestations, and treatment of PCG.
• To emphasize the need for early detection and resource allocation to prevent avoidable blindness.

Main Methods:

• Review of existing literature on primary congenital glaucoma.
• Analysis of genetic loci and associated genes implicated in PCG.
• Discussion of clinical presentation, diagnostic methods, and treatment options.

Main Results:

• PCG is an autosomal recessive disorder linked to genetic mutations at loci GLC3A (CYP1B1), GLC3B, GLC3C, and GLC3D (LTPB2).
• Symptoms include corneal swelling, increased eye size (buphthalmos), opacity, and optic nerve damage due to elevated IOP.
• High consanguinity rates correlate with PCG prevalence in certain communities.

Conclusions:

• Early screening and diagnosis of PCG in children are crucial for preventing irreversible vision loss.
• Effective treatments like trabeculectomy and gonioscopy exist, but access and resources are critical, especially in developing countries.
• Further research into the genetic factors and environmental influences of PCG is necessary to improve outcomes and reduce global blindness.